Front Row Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-18
| Closed | -$4.92K | – | 542 |
|
|
2024
Q2 | $4.92K | Sell |
18
-2
| -10% | -$546 | ﹤0.01% | 731 |
|
|
2024
Q1 | $6.92K | Buy |
+20
| New | +$6.92K | ﹤0.01% | 667 |
|
|
2023
Q4 | – | Sell |
-17
| Closed | -$6.09K | – | 514 |
|
|
2023
Q3 | $6.09K | Hold |
17
| – | – | ﹤0.01% | 627 |
|
|
2023
Q2 | $6K | Buy |
17
+4
| +31% | +$1.41K | ﹤0.01% | 624 |
|
|
2023
Q1 | $6K | Sell |
13
-1
| -7% | -$462 | ﹤0.01% | 627 |
|
|
2022
Q4 | $6K | Buy |
14
+5
| +56% | +$2.14K | ﹤0.01% | 594 |
|
|
2022
Q3 | $4K | Hold |
9
| – | – | ﹤0.01% | 680 |
|
|
2022
Q2 | $4K | Buy |
9
+1
| +13% | +$444 | ﹤0.01% | 704 |
|
|
2022
Q1 | $5K | Sell |
8
-4
| -33% | -$2.5K | ﹤0.01% | 709 |
|
|
2021
Q4 | $9K | Sell |
12
-2
| -14% | -$1.5K | ﹤0.01% | 594 |
|
|
2021
Q3 | $10K | Hold |
14
| – | – | ﹤0.01% | 558 |
|
|
2021
Q2 | $11K | Hold |
14
| – | – | ﹤0.01% | 532 |
|
|
2021
Q1 | $8K | Buy |
14
+1
| +8% | +$571 | ﹤0.01% | 593 |
|
|
2020
Q4 | $8K | Hold |
13
| – | – | ﹤0.01% | 561 |
|
|
2020
Q3 | $7K | Sell |
13
-4
| -24% | -$2.15K | ﹤0.01% | 585 |
|
|
2020
Q2 | $8K | Hold |
17
| – | – | 0.01% | 513 |
|
|
2020
Q1 | $7K | Sell |
17
-2
| -11% | -$824 | ﹤0.01% | 533 |
|
|
2019
Q4 | $7K | Hold |
19
| – | – | ﹤0.01% | 531 |
|
|
2019
Q3 | $6K | Buy |
19
+4
| +27% | +$1.26K | ﹤0.01% | 545 |
|
|
2019
Q2 | $5K | Hold |
15
| – | – | ﹤0.01% | 568 |
|
|
2019
Q1 | $5K | Hold |
15
| – | – | ﹤0.01% | 569 |
|
|
2018
Q4 | $3K | Hold |
15
| – | – | ﹤0.01% | 654 |
|
|
2018
Q3 | $4 | Buy |
+15
| New | +$4 | ﹤0.01% | 592 |
|